Post Stroke Depression

More documents

Recommendations

Info

Disclosure of Potential for Conflict ofInterestDr. Tim Holden FRCPCPost Stroke Depression: Assessmentand TreatmentFINANCIAL DISCLOSURE: Occasional Honoraria fromTEVA and Lundbeck for community CME eventsOther: None
Objectives•To appreciate the incidence, prevalence and iompact of mooddisorders following stroke (PSD)•To review screening instruments and timing of assessment ofPSD•To comment on possible mechanisms of PSD•To review the pharmacological treatments used in strokepatients•To mention recent definitive studies on antidepressants•To comment on the differences between treatment of poststrokedepression and “non-medical” depression (MDD)•To promote discussion of resources available locally
Page 4: Post-Stroke Depression Epidemiology
Page 7 and 8: Depression in Medical illness:The (
Page 9 and 10: PDQ-9 -Example
Page 11 and 12: EMPIRICAL STUDIES•There are many
Page 13 and 14: …but there are positive studies
Page 15 and 16: Recommended ReviewWilliam Feinberg
Page 17 and 18: Results of a Pool of Studies Assess
Page 19 and 20: Are there stroke-specific factors?
Page 21 and 22: Escitalopram and post-stroke cognit
Page 23 and 24: STAR*D SequencedTreatment Alternati
Page 25 and 26: The Lancet 2009: Cipriani et al.Bac
Page 27: Efficacy Acceptability• Mirtazepi

Post Stroke Depression

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?